Saniona AB (FRA:30S) OCF Margin %: -1,068.28% (As of Mar. 2026)


FRA:30S Saniona AB FRA:30S
67 GF Score
Price €1.13
GF Value €2.41
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Saniona AB OCF Margin %?

Saniona AB FRA:30S +1.16% 67 OCF Margin % is -1,068.28% as of Mar. 2026. GuruFocus rates FRA:30S with a GF Score™ of 67/100 and a GF Value™ of €2.41 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 959 Biotechnology companies, Saniona AB ranks better than 96.98% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Saniona AB's Cash Flow from Operations for the three months ended in Mar. 2026 was €-4.65 Mil. Saniona AB's Revenue for the three months ended in Mar. 2026 was €0.44 Mil. Therefore, Saniona AB's OCF Margin % for the quarter that ended in Mar. 2026 was -1,068.28%.

As of today, Saniona AB's current OCF Yield % is 14.58%.

The historical rank and industry rank for Saniona AB's OCF Margin % or its related term are showing as below:

FRA:30S' s OCF Margin % Range Over the Past 10 Years
Min: -3292.98   Med: -353.95   Max: 74.16
Current: 58.97

During the past 13 years, the highest OCF Margin % of Saniona AB was 74.16%. The lowest was -3292.98%. And the median was -353.95%.

FRA:30S's OCF Margin % is ranked better than
96.98% of 959 companies
in the Biotechnology industry
Industry Median: -66.52 vs FRA:30S: 58.97

Saniona AB OCF Margin % Related Terms

Saniona AB OCF Margin % Historical Data

* Premium members only.

The historical data trend for Saniona AB's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Saniona AB OCF Margin % Chart

Saniona AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3,293.53 -1,842.37 -430.90 74.16 63.04

Saniona AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -326.06 112.57 90.40 -1,671.26 -1,068.28

FRA:30S vs VRTX, REGN, ALNY: OCF Margin % Comparison

For the Biotechnology subindustry, Saniona AB's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Saniona AB OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Saniona AB's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Saniona AB's OCF Margin % falls into.


FRA:30S
67GF Score
Saniona AB FRA:30S
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Saniona AB OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Saniona AB's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=25.165/39.918
=63.04 %

Saniona AB's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-4.647/0.435
=-1,068.28 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -1,068.28% mean?
Saniona AB (FRA:30S) has a OCF Margin % of -1,068.28% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Saniona AB and its competitors. According to the industry distribution chart, Saniona AB ranks #29 out of 959 companies in the Biotechnology industry, placing it in the top 3%.
Is Saniona AB's OCF Margin % too high?
Saniona AB's current OCF Margin % is -1,068.28%. Based on the distribution chart, Saniona AB ranks #29 out of 959 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Saniona AB has a GF Score™ of 67/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Saniona AB's OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Saniona AB ranks #29 out of 959 companies for OCF Margin %. This places Saniona AB in the top 3% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Saniona AB and its competitors. Saniona AB's current OCF Margin % is -1,068.28%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Saniona AB stock overvalued right now?
Based on GuruFocus' analysis, Saniona AB (FRA:30S) is currently considered Significantly Undervalued. The stock's GF Value™ is €2.41, compared to a current price of €1.13 — trading 53% below its estimated fair value. The current OCF Margin % is -1,068.28%. Saniona AB's overall GF Score™ is 67/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Saniona AB (FRA:30S), the current OCF Margin % is -1,068.28% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Saniona AB (FRA:30S) Overvalued in 2026?

Based on GuruFocus' analysis, Saniona AB stock appears to be undervalued. The current stock price of €1.13 is trading 53% below its estimated GF Value™ of €2.41. GuruFocus considers Saniona AB to be Significantly Undervalued.

Key valuation signals for FRA:30S:

  • OCF Margin %: -1,068.28%
  • GF Value™: €2.41 vs. price of €1.13 (53% below fair value)
  • GF Score™: 67/100 with 3 warning signs

No single metric tells the full story. See the FRA:30S stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Saniona AB Business Description

Address Murervangen 42, Glostrup, DNK, DK-2600
Saniona AB researches and develops drugs for the treatment of diseases of the central nervous system, autoimmune diseases, metabolic diseases, and the treatment of pain. It develops a technology platform that enables the investigation of all types of ion channel drug targets. Its research is focused on GABAA receptors, nicotinic acetylcholine receptors, and potassium channels. The company product pipeline includes Tesomet, SAN711, Tesofensine, SAN903, and SAN2219. Geographically, it operates in USA, Sweden, Germany, Denmark, and United Kingdom, out of which it derives maximum revenue from USA.
67GF Score

Get the complete analysis for FRA:30S

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.13
Price
€2.41
GF Value